Sage Therapeutic Correlations
SAGE Stock | USD 5.79 0.32 5.85% |
The current 90-days correlation between Sage Therapeutic and Terns Pharmaceuticals is 0.02 (i.e., Significant diversification). The correlation of Sage Therapeutic is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Sage Therapeutic Correlation With Market
Weak diversification
The correlation between Sage Therapeutic and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sage Therapeutic and DJI in the same portfolio, assuming nothing else is changed.
Sage |
Moving together with Sage Stock
0.69 | EQ | Equillium | PairCorr |
0.69 | ME | 23Andme Holding Upward Rally | PairCorr |
0.81 | VALN | Valneva SE ADR | PairCorr |
0.65 | DNTH | Dianthus Therapeutics | PairCorr |
0.73 | DRMA | Dermata Therapeutics | PairCorr |
0.81 | DRRX | Durect | PairCorr |
0.76 | DTIL | Precision BioSciences | PairCorr |
0.67 | VINC | Vincerx Pharma | PairCorr |
0.84 | VIRX | Viracta Therapeutics | PairCorr |
0.82 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.74 | VTGN | VistaGen Therapeutics | PairCorr |
Moving against Sage Stock
0.73 | VCYT | Veracyte | PairCorr |
0.66 | VERA | Vera Therapeutics | PairCorr |
0.63 | SABSW | SAB Biotherapeutics | PairCorr |
0.56 | VCEL | Vericel Corp Ord | PairCorr |
0.42 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.37 | DSGN | Design Therapeutics | PairCorr |
0.35 | VANI | Vivani Medical | PairCorr |
0.32 | DMAC | DiaMedica Therapeutics Trending | PairCorr |
0.73 | VSTM | Verastem Trending | PairCorr |
0.72 | VRNA | Verona Pharma PLC | PairCorr |
0.66 | VTRS | Viatris | PairCorr |
0.64 | DVAX | Dynavax Technologies | PairCorr |
0.34 | DYAI | Dyadic International | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sage Stock performing well and Sage Therapeutic Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sage Therapeutic's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
APLS | 2.47 | (0.21) | 0.00 | (0.21) | 0.00 | 4.48 | 15.97 | |||
TERN | 3.37 | (0.33) | 0.00 | (0.22) | 0.00 | 6.02 | 34.09 | |||
DAWN | 2.06 | (0.09) | (0.04) | 0.01 | 2.77 | 3.84 | 11.44 | |||
BPMC | 1.82 | (0.08) | (0.02) | 0.06 | 2.57 | 4.90 | 14.28 | |||
CERE | 0.77 | 0.06 | (0.05) | 0.49 | 0.94 | 1.91 | 6.40 | |||
MRTX | 2.24 | (0.41) | 0.00 | 3.37 | 0.00 | 4.02 | 16.13 | |||
AMLX | 4.36 | 1.48 | 0.30 | 1.40 | 4.11 | 10.06 | 33.56 | |||
RLAY | 3.40 | (0.84) | 0.00 | (0.09) | 0.00 | 4.82 | 66.18 | |||
STOK | 2.63 | (0.30) | 0.00 | (0.10) | 0.00 | 4.68 | 21.35 | |||
PLRX | 2.74 | (0.11) | 0.01 | 0.08 | 3.13 | 5.37 | 24.35 |
Sage Therapeutic Corporate Management
Anne Esq | General VP | Profile | |
Jim Doherty | Chief Officer | Profile | |
Aaron MD | Medical Development | Profile | |
Christopher Benecchi | Chief Officer | Profile | |
Laura MD | Chief Officer | Profile | |
Heinrich Schlieker | Senior Operations | Profile | |
Albert Robichaud | Chief Scientific Officer | Profile |